Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Colorectal Neoplasms

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 149 articles: HTML format

Single Articles

June 2026
1. FUNAKOSHI K, Sasaki K, Hata K, Nozawa H, et al
   Genomic Profiling of Cancerous Areas, Dysplasia, and Background Mucosa in Ulcerative Colitis-associated Colorectal Cancer.
   Anticancer Res. 2026;46:3281-3291.
   PubMed     Abstract available
   
   
   
2. MAEDA K, Koyama S, Kawada K, Hayashi T, et al
   Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan-Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer.
   Anticancer Res. 2026;46:3191-3203.
   PubMed     Abstract available
   
   
   
3. RAFIQUE A, Koh YS
   Unveiling the Anti-tumor Actions and Therapeutic Potential of Calcitriol in Colorectal Cancer.
   Anticancer Res. 2026;46:2985-3004.
   PubMed     Abstract available
   
   
   
4. MURAI Y, Sugimoto K, Irie T, Fujisaki T, et al
   Circulating Tumor DNA Methylation Level Is a More Accurate Prognostic Biomarker in Colon Cancer.
   Anticancer Res. 2026;46:3267-3280.
   PubMed     Abstract available
   
   
   May 2026
5. SHIRAISHI T, Tominaga T, Nonaka T, Takamura Y, et al
   Prognostic Significance of the Lymph Node Ratio in Obstructive Colorectal Cancer: A Retrospective Multicenter Study.
   Anticancer Res. 2026;46:2703-2711.
   PubMed     Abstract available
   
   
   
6. ISHII K, Tauchi Y, Yano T
   Evaluation of Combined Treatment With Atorvastatin and SREBP2 Inhibitors Against Colorectal Cancer Cells Under Two-dimensional and Three-dimensional Culture Models.
   Anticancer Res. 2026;46:2403-2415.
   PubMed     Abstract available
   
   
   
7. SALIMIAGHDAM N, Yang X, Liang H
   The Ovarian Portal: An Unusual Pathway to Discovery, A Rare Initial Manifestation of Colon Cancer.
   Anticancer Res. 2026;46:2915-2923.
   PubMed     Abstract available
   
   
   
8. ADACHI Y, Matsuda T, Inubushi S, Yasuda K, et al
   Serum Extracellular Vesicles Double-positive for CD9 and CD147 or for CD9 and CD63 Decrease After Surgical Resection in Patients With Colorectal Cancer: Potential Biomarkers of Residual Tumor.
   Anticancer Res. 2026;46:2345-2352.
   PubMed     Abstract available
   
   
   
9. KYROS E, Mylonakis A, Kastanaki P, Velliou RI, et al
   Cytometry by Time-of-Flight for Profiling Therapeutic Response in Colorectal Cancer: Strengths, Limitations, and Translational Challenges.
   Anticancer Res. 2026;46:2297-2316.
   PubMed     Abstract available
   
   
   
10. KOBAYASHI Y, Takano Y, Fukushima A, Takishima T, et al
    Prognostic Impact of the Geriatric Nutritional Risk Index in Elderly Patients With Colorectal Cancer.
    Anticancer Res. 2026;46:2753-2762.
    PubMed     Abstract available
    
    
    
11. ISHII K, Yano T
    6-O-Carboxypropyl-alpha-Tocotrienol Enhances the Anticancer Effects of Bortezomib Without Suppressing NRF1 and NRF3 in Colorectal Cancer Cells.
    Anticancer Res. 2026;46:2375-2386.
    PubMed     Abstract available
    
    
    
12. KIM J, Han Q, Li S, Kang BM, et al
    Sulfasalazine an Inhibitor of System x(C) (-) (Cystine/glutamate Antiporter), Combined With Recombinant Methioninase, Inhibits Both Cancer and Normal Cells, Suggesting Lack of Cancer Selectivity of Cysteine Restriction.
    Anticancer Res. 2026;46:2353-2359.
    PubMed     Abstract available
    
    
    
13. KOMORI K, Kinoshita T, Ouchi A, Kishida T, et al
    Laparotomy After Total Pelvic Exenteration: Current Status and Techniques for Ileal Conduit Preservation.
    Anticancer Res. 2026;46:2735-2741.
    PubMed     Abstract available
    
    
    
14. ZHANG Z, Tu H, Han Z, Wang S, et al
    Profiling of Lysine Lactylation Reveals Its Proliferation-promoting Functions in Colorectal Cancer Cells.
    Anticancer Res. 2026;46:2565-2581.
    PubMed     Abstract available
    
    
    
15. THI TN, Nguyen VT, Thanh HD, Kwon SY, et al
    Inhibition of AP-1 Reduces CD46-mediated Invasion of Bladder and Colon Cancer Cells.
    Anticancer Res. 2026;46:2525-2539.
    PubMed     Abstract available
    
    
    
16. MATOBA D, Saito T, Noda T, Uemura M, et al
    PD-1(+)Tim-3(+)CD103(+) CD8(+) Tumor-infiltrating Lymphocytes Are Associated With Favorable Outcomes in Colorectal Cancer.
    Anticancer Res. 2026;46:2387-2401.
    PubMed     Abstract available
    
    
    April 2026
17. KONDOR AE, Vereczkei A, Varga P, Sindler LD, et al
    The Role of MRI in the Preoperative Staging of Rectal Cancer: Ten-year Experience from a Single Tertiary Center.
    Anticancer Res. 2026;46:2125-2132.
    PubMed     Abstract available
    
    
    
18. SAELIM P, Ei ZZ, Racha S, Yokoya M, et al
    Methoxy and Ketone Substitutions of Resveratrol Enhance Its Anticancer Activity by Increasing MEK and ERK Binding Affinity in Colorectal Cancer Cells.
    Anticancer Res. 2026;46:1957-1966.
    PubMed     Abstract available
    
    
    
19. KATAYAMA R, Aoki T, Tashiro Y, Hirai T, et al
    Relationship Between Histopathological Growth Patterns and Indocyanine Green Fluorescence in Colorectal Liver Metastases.
    Anticancer Res. 2026;46:2087-2093.
    PubMed     Abstract available
    
    
    March 2026
20. LOPES C, Macedo-Silva C, Farinha M, Costa J, et al
    Exploring SLC1A5 (ASCT2), SLC7A5, and SLC3A2 (LAT1) Genetic Variants in Colorectal Cancer: Implications for Prognosis and Personalized Care.
    Anticancer Res. 2026;46:1281-1292.
    PubMed     Abstract available
    
    
    
21. MAIMON O, Nisman B, Ben-David I, Kuznetz A, et al
    Autologous Tumor Vaccination in Melanoma and Colon Cancer Patients With Recurrent Liver Metastases: A Case Series.
    Anticancer Res. 2026;46:1569-1575.
    PubMed     Abstract available
    
    
    
22. GKEKAS I, Novotny J, Kaprio T, Fabian P, et al
    Risk of Non-colorectal Malignancies in Sporadic Versus Lynch Syndrome-associated dMMR Colorectal Cancer.
    Anticancer Res. 2026;46:1489-1496.
    PubMed     Abstract available
    
    
    
23. KAUR H, Bhall GIS, Lauder C, DA Silva N, et al
    Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Outcomes for Colorectal and Mesothelioma Peritoneal Metastases: A 12-year Study.
    Anticancer Res. 2026;46:1507-1515.
    PubMed     Abstract available
    
    
    
24. TAKCI RG, Sarac B, Hacisuleyman L, Sahinbas B, et al
    Synergistic Anticancer Effects of the PLK1 Inhibitor BI-2536 and beta-Glucan in Colon and Gastric Cancer Cells.
    Anticancer Res. 2026;46:1461-1474.
    PubMed     Abstract available
    
    
    February 2026
25. KIM J, Han Q, Li S, Kang BM, et al
    Lack of Cancer Specificity of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 in Combination With Recombinant Methioninase In Vitro.
    Anticancer Res. 2026;46:705-712.
    PubMed     Abstract available
    
    
    
26. TANDA H, Shibutani M, Seki Y, Nishiyama T, et al
    The Usefulness of the Modified Controlling Nutritional Status Score for Assessing Prognosis in Patients With Colorectal Cancer.
    Anticancer Res. 2026;46:1097-1105.
    PubMed     Abstract available
    
    
    
27. YAMANAKA R, Matsumoto N, Murase R, Kubota Y, et al
    Polymorphisms of FGFR Pathway-related Factors and Capecitabine-induced Hand-foot Syndrome in Japanese Patients With Colorectal Cancer.
    Anticancer Res. 2026;46:835-846.
    PubMed     Abstract available
    
    
    
28. OKADO S, Nakamura S, Sugihara M, Kinoshita F, et al
    Prognostic Factors for Pulmonary Metastasectomy for Colorectal Cancer: A Propensity Score Matching Analysis.
    Anticancer Res. 2026;46:1143-1152.
    PubMed     Abstract available
    
    
    
29. KUWATA D, Shimoda H, Miura T, Chiba T, et al
    Anatomical-specific Lymphatic Route Beyond Mesorectal Fascia: Analyses from Female Cadavers and Patients With Rectal Cancer.
    Anticancer Res. 2026;46:885-899.
    PubMed     Abstract available
    
    
    
30. INOUE A, Ota H, Matsuura Y, Munakata K, et al
    First-line FOLFOXIRI-based Chemotherapy for Unresectable Metastatic Colorectal Cancer: Real-world Outcomes, Safety, and Conversion Surgery.
    Anticancer Res. 2026;46:975-985.
    PubMed     Abstract available
    
    
    
31. SEKI Y, Shibutani M, Tanda H, Tsukida T, et al
    Impact of the Immunonutritional Status on the Feasibility of Subsequent Treatment After the Discontinuation of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2026;46:1117-1122.
    PubMed     Abstract available
    
    
    
32. KIM HB, Lee HJ, Park SG
    Oncogenic Role and Clinical Significance of NPM1 in Colorectal Cancer via the AKT/mTOR Signaling Pathway.
    Anticancer Res. 2026;46:727-736.
    PubMed     Abstract available
    
    
    
33. KUO CY, Liao TL, Hsu FT, Chang CM, et al
    Lenvatinib Exhibits Potent Anti-tumor Activity and Favorable Safety Profile in a Colorectal Cancer Xenograft Model.
    Anticancer Res. 2026;46:797-810.
    PubMed     Abstract available
    
    
    January 2026
34. KOSUGE T, Mazaki J, Kasahara K, Osakabe H, et al
    Prediction of the Clinicopathological Prognosis of Colon Cancer After Radical Resection Using Artificial Intelligence "TabNet".
    Anticancer Res. 2026;46:467-474.
    PubMed     Abstract available
    
    
    
35. NARIHIRO S, Kitaguchi D, Ryu S, Fukuda M, et al
    Short-term Outcomes of Robotic-assisted Versus Laparoscopic Right Hemicolectomy for Right-sided Colon Cancer: A Retrospective Study.
    Anticancer Res. 2026;46:493-501.
    PubMed     Abstract available
    
    
    
36. KIM BH, Lee J, Lee D, Kim K, et al
    Immune Microenvironment Signatures Predict Response and Survival in Rectal Cancer Patients After Neoadjuvant Chemoradiation.
    Anticancer Res. 2026;46:123-134.
    PubMed     Abstract available
    
    
    
37. MATSUBARA D, Soga K, Fujita Y, Ochi F, et al
    Oncological Outcomes of Laparoscopic Surgery With Stent Bridge in Stage II-III Obstructive Colorectal Cancer.
    Anticancer Res. 2026;46:347-357.
    PubMed     Abstract available
    
    
    
38. KATAYAMA H, Noda K, Tominaga T, Hashimoto S, et al
    Effect of the Endoscopic Surgical Skill Qualification System for Colorectal Cancer Surgery With Multivisceral Resection on Long-term Outcomes: Japanese Multicenter Analysis.
    Anticancer Res. 2026;46:457-465.
    PubMed     Abstract available
    
    
    
39. NODA K, Tominaga T, Hashimoto S, Yamashita M, et al
    Effect of Pathological Response After Neoadjuvant Chemotherapy on Long-term Outcomes in Locally Advanced Colorectal Cancer: A Japanese Multicenter Study.
    Anticancer Res. 2026;46:327-336.
    PubMed     Abstract available
    
    
    
40. OHTAKI KI, Takeuchi R, Iwayama K, Chuma M, et al
    Evaluation of Regorafenib-induced Pancreatic Enzyme Elevation in Metastatic Colorectal Cancer Treatment.
    Anticancer Res. 2026;46:359-369.
    PubMed     Abstract available
    
    
    December 2025
41. MUECKE R, Fakhrian K, Gosenheimer R, Schmitz V, et al
    Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer: A Single-institutional Real-world Study.
    Anticancer Res. 2025;45:5513-5521.
    PubMed     Abstract available
    
    
    
42. KIM J, Han Q, Li S, Kang BM, et al
    The Combination of Recombinant Methioninase and Low-dose Chloroquine Selectively Eradicates Colon-Cancer Cells Without Apparent Toxicity on Co-cultured Normal Fibroblasts.
    Anticancer Res. 2025;45:5313-5320.
    PubMed     Abstract available
    
    
    
43. FURUKAWA K, Haruki K, Shirai Y, Onda S, et al
    Pulmonary Emphysema Assessed by the Goddard Score Predicts Outcomes After Hepatic Resection for Colorectal Liver Metastases.
    Anticancer Res. 2025;45:5765-5772.
    PubMed     Abstract available
    
    
    
44. YONEMITSU K, Kasashima H, Fukuoka T, Tanaka A, et al
    Successful Reconstruction of Recurrent Perineal Hernia After APR Using a Vertical Rectus Abdominis Myocutaneous Flap: A Salvage Option for a Refractory Case.
    Anticancer Res. 2025;45:5813-5817.
    PubMed     Abstract available
    
    
    November 2025
45. KOTAKE Y, Tanigawa Y, Ikenaga H, Kitagawa T, et al
    OIP5-AS1 Positively Regulates the Proliferation of Colorectal Cancer Cells by Repressing Apoptosis.
    Anticancer Res. 2025;45:4783-4790.
    PubMed     Abstract available
    
    
    
46. KIM MW, Kim D, Lee SE, Ahn J, et al
    JI-CJ002, a Natural Herbal Formula, Enhances the Antitumor Efficacy of FOLFOX in Colorectal Cancer by Suppressing the DDR Pathway.
    Anticancer Res. 2025;45:4987-5000.
    PubMed     Abstract available
    
    
    
47. MARUTA H, Noda K, Tominaga T, Hashimoto S, et al
    Efficacy and Safety of Robotic Surgery for Bulky Colorectal Tumors.
    Anticancer Res. 2025;45:5139-5146.
    PubMed     Abstract available
    
    
    
48. SHIMASAKI M, Kiyozumi Y, Ohmura R, Matsuishi K, et al
    Pathological Complete Response in Locally-advanced MSI-H/dMMR Sigmoid Colon Cancer Treated With Pembrolizumab and Abdominal Reconstruction.
    Anticancer Res. 2025;45:5239-5246.
    PubMed     Abstract available
    
    
    
49. TSAI YF, Wu MH, Lin TC, Yueh TC, et al
    Contribution of Xeroderma Pigmentosum Complementation Group C Genotypes to Colorectal Cancer in Taiwanese.
    Anticancer Res. 2025;45:4751-4763.
    PubMed     Abstract available
    
    
    
50. KITAGUCHI D, Enomoto T, Hoshiai S, Furuya K, et al
    Preoperative Risk Analysis for Postoperative Recurrence in Locally Advanced Rectal Cancer Following Chemoradiotherapy.
    Anticancer Res. 2025;45:5147-5157.
    PubMed     Abstract available
    
    
    
51. HOSOKAWA A, Yamada R, Otsuki Y, Tamura H, et al
    Remarkable and Durable Tumor Response to Pembrolizumab in Locally Advanced dMMR/MSI-H Rectal Cancer.
    Anticancer Res. 2025;45:5069-5076.
    PubMed     Abstract available
    
    
    October 2025
52. TAKAHASHI H, Kojima D, Miyasaka Y, Wada H, et al
    Neoadjuvant Chemotherapy for Initially Resectable Metachronous Colorectal Cancer Liver Metastases Is Associated With Early Postoperative Relapse.
    Anticancer Res. 2025;45:4547-4564.
    PubMed     Abstract available
    
    
    
53. JIMENEZ PB, Merly AA, Shekouhi R, Demirors B, et al
    Survival Impact and Sociodemographic Correlates of Colon Cancer Surgery Refusal.
    Anticancer Res. 2025;45:4305-4313.
    PubMed     Abstract available
    
    
    
54. KANG BM, Han Q, Li S, Kim JS, et al
    Recombinant Methioninase Selectively Eliminates Cancer Cells Co-cultured With Normal Fibroblasts Indicating the High-Precision Efficacy of Targeting Methionine Addiction of Cancer.
    Anticancer Res. 2025;45:4193-4200.
    PubMed     Abstract available
    
    
    
55. FUKATA K, Ogura A, Murata Y, Kobayashi R, et al
    The Impact of Adjuvant Chemotherapy in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemotherapy: A Propensity Score Matching Cohort Study.
    Anticancer Res. 2025;45:4431-4439.
    PubMed     Abstract available
    
    
    
56. CIFTCI M, Ozgur E, Kulle CB, Gezer U, et al
    Exploring the Clinical Significance of Circulating H19 lncRNA and IGF-2 mRNA in Colorectal Carcinoma.
    Anticancer Res. 2025;45:4243-4251.
    PubMed     Abstract available
    
    
    
57. HARISI R, Jaray B, Zsirka A, Kulka J, et al
    Differential PCNA Expression Between Neoplastic and Adjacent Mucosa as a Prognostic Marker in Colorectal Adenoma-Carcinoma Progression.
    Anticancer Res. 2025;45:4415-4430.
    PubMed     Abstract available
    
    
    September 2025
58. WADA N, Nishida N, Takeda M, Sekido Y, et al
    Efficacy and Safety of S-1 and Oxaliplatin With Radiotherapy for Anorectal Cancer.
    Anticancer Res. 2025;45:3847-3857.
    PubMed     Abstract available
    
    
    
59. OTANI K, Kazama K, Aoyama T, Hashimoto I, et al
    Geriatric Nutritional Risk Index Predicts Prognosis in Older Patients With Colorectal Cancer: A Multicenter Study.
    Anticancer Res. 2025;45:4015-4025.
    PubMed     Abstract available
    
    
    
60. KOKAINE L, Daneberga Z, Satcs M, Zvina D, et al
    The Prognostic Role of microRNAs 142-5p, 182-3p, and 99a-3p in Locally Advanced Rectal Cancer Patients.
    Anticancer Res. 2025;45:3895-3912.
    PubMed     Abstract available
    
    
    
61. KIM J, Han Q, Li S, Kang BM, et al
    Combinations of Salmonella typhimurium A1-R, Recombinant Methioninase, and Chloroquine, Each Targeting Fundamental Cancer Hallmarks, Are Selectively Effective on Colon Cancer Cells Compared to Normal Fibroblasts.
    Anticancer Res. 2025;45:3661-3668.
    PubMed     Abstract available
    
    
    
62. NOZAWA H, Kasuga SO, Murono K, Sasaki K, et al
    Effects of Neoadjuvant Treatments on Mesorectal Computed Tomography Values and Tumor Regression in Rectal Cancer.
    Anticancer Res. 2025;45:3921-3930.
    PubMed     Abstract available
    
    
    
63. KIMURA N, Hiraki M, Furukawa S, Ikuno H, et al
    Oncological Outcomes of Varying Resection Margin Lengths in Colon Cancer Surgery: A Retrospective Analysis.
    Anticancer Res. 2025;45:4005-4013.
    PubMed     Abstract available
    
    
    August 2025
64. OGURA A, Murata Y, Sando M, Kobayashi R, et al
    Response-guided Strategy Based on Induction Chemotherapy Without Routine Use of Radiotherapy for Locally Advanced Rectal Cancer.
    Anticancer Res. 2025;45:3393-3398.
    PubMed     Abstract available
    
    
    
65. MUKOHYAMA J, Saito I, Mochizuki S, Ota Y, et al
    Endometrial Cancer Metastatic to the Sigmoid Colon and Pelvic Retroperitoneal Space: A Case Report.
    Anticancer Res. 2025;45:3567-3573.
    PubMed     Abstract available
    
    
    
66. LEE S, Koh JW, Lee JH, Park SJ, et al
    Silencing of Acyl-CoA Thioesterase 7 Inhibits Proliferation and Metastatic Potential in Colorectal Cancer Cells.
    Anticancer Res. 2025;45:3315-3325.
    PubMed     Abstract available
    
    
    July 2025
67. HUANG CW, Yang JS, Tsai YF, Kuo SC, et al
    Anti-cancer Effects of a Novel Curcumin Derivative, 4,4-Diallyl Curcumin Bis(2,2-Hydroxymethyl)Propanoate (35e), on Radio-resistant Colorectal Cancer Cells.
    Anticancer Res. 2025;45:2891-2904.
    PubMed     Abstract available
    
    
    
68. ASANO Y, Han Q, Li S, Mizuta K, et al
    The Combination of the Autophagy Inhibitor Chloroquine and Recombinant Methioninase Has Selective Synergistic Efficacy on Human Colon Cancer Cells But Not on Normal Human Fibroblasts.
    Anticancer Res. 2025;45:2825-2831.
    PubMed     Abstract available
    
    
    
69. KIM J, Han Q, Kang BM, Mizuta K, et al
    The Triple Combination of Recombinant Methioninase, Rapamycin, and Chloroquine Synergistically Eradicates HCT116 Colon Cancer Cells.
    Anticancer Res. 2025;45:2773-2779.
    PubMed     Abstract available
    
    
    
70. LEE J, Kim H, Moon J, Nualsanit T, et al
    Damnacanthal Suppresses TCF4 Expression in Colorectal Cancer Cells.
    Anticancer Res. 2025;45:2847-2858.
    PubMed     Abstract available
    
    
    
71. KANG BM, Han Q, Li S, Mizuta K, et al
    The Conditions of Non-rescuability of Methioninase-treated Cancer Cells by Methionine Replenishment: The Point of No Return.
    Anticancer Res. 2025;45:2817-2823.
    PubMed     Abstract available
    
    
    
72. NGUYEN MLT, Bui LA, Pham C, Nham PLT, et al
    Adiponectin Receptor Agonist Suppresses Human Colorectal Cancer.
    Anticancer Res. 2025;45:3059-3068.
    PubMed     Abstract available
    
    
    
73. VAN BUSSEL MTJ, Bravenboer N, Essen HV, Snaebjornsson P, et al
    Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial.
    Anticancer Res. 2025;45:3137-3147.
    PubMed     Abstract available
    
    
    
74. SUETSUGU F, Tadokoro T, Fujita K, Fujihara S, et al
    Antitumor Effects of Epigallocatechin-3-Gallate on Colorectal Cancer: An In Vitro and In Vivo Study.
    Anticancer Res. 2025;45:2937-2947.
    PubMed     Abstract available
    
    
    June 2025
75. MINAMI S, Miyoshi N, Fujino S, Yasui M, et al
    Role of the Circadian Clock Gene DEC1 in Chemosensitivity and Apoptosis in Colorectal Cancer.
    Anticancer Res. 2025;45:2309-2328.
    PubMed     Abstract available
    
    
    
76. YU X, Tsunedomi R, Hazama S, Nakagami Y, et al
    Immunogenicity of Neoantigens in Colorectal Cancer: Potential Influence of Tumor Mutation Burden, Stages, and Metastasis.
    Anticancer Res. 2025;45:2385-2399.
    PubMed     Abstract available
    
    
    
77. ANDO Y, Orito H, Mizuno T, Katsuno H, et al
    Effect of a Biweekly Dosing Schedule on Severe Neutropenia Induced by Trifluridine/Tipiracil in Colorectal Cancer.
    Anticancer Res. 2025;45:2587-2594.
    PubMed     Abstract available
    
    
    
78. ESKELINEN M, Selander T, Guimaraes DP, Kaarniranta K, et al
    Four Different Artificial Intelligence Models Versus Logistic Regression to Enhance the Diagnostic Accuracy of Fecal Immunochemical Test in the Detection of Colorectal Carcinoma in a Screening Setting.
    Anticancer Res. 2025;45:2477-2491.
    PubMed     Abstract available
    
    
    
79. KODAMA H, Yamaguchi T, Kameishi S, Kadono T, et al
    Tumor Budding Grade and T Stage as Recurrence Predictors of High-risk Stage II Colorectal Cancer.
    Anticancer Res. 2025;45:2619-2628.
    PubMed     Abstract available
    
    
    
80. KATAOKA A, Kawasaki T, Kaira K, Hirano Y, et al
    Pathological Investigation of Grasping-related Mesenteric Injury During Laparoscopic Colorectal Cancer Resection.
    Anticancer Res. 2025;45:2493-2499.
    PubMed     Abstract available
    
    
    
81. ASANO Y, Han Q, Li S, Mizuta K, et al
    Selective Synergy of Ivermectin Combined With Recombinant Methioninase Against Colon-Cancer Cells in Contrast to Normal Fibroblasts.
    Anticancer Res. 2025;45:2257-2263.
    PubMed     Abstract available
    
    
    
82. KOBAYASHI Y, Takano Y, Matsukida S, Takishima T, et al
    Prognostic Nutritional Index Is the Key Prognostic Factor in Elderly Patients With Colorectal Cancer.
    Anticancer Res. 2025;45:2595-2603.
    PubMed     Abstract available
    
    
    May 2025
83. HWANG HH, Yoo JS, Je JH, Lee HC, et al
    SH003 Inhibits Proliferation and Induces Apoptosis in Colon Cancer Through the RTK-STAT3 Pathway.
    Anticancer Res. 2025;45:1965-1980.
    PubMed     Abstract available
    
    
    
84. IZUTANI Y, Ogino T, Fujii M, Sekido Y, et al
    Appendectomy Mitigates Ulcerative Colitis Activity and Delays Colorectal Cancer Onset: A Retrospective Cohort Study.
    Anticancer Res. 2025;45:2205-2214.
    PubMed     Abstract available
    
    
    April 2025
85. OKEMOTO D, Yamaguchi T, Sugino K, Matsuo N, et al
    Chemotherapy Efficacy in Patients With Colorectal Cancer Experiencing Early Recurrence During or After Adjuvant Chemotherapy.
    Anticancer Res. 2025;45:1695-1705.
    PubMed     Abstract available
    
    
    
86. YUEH TC, Chen YJ, Mong MC, Ke TW, et al
    The Contribution of Interleukin-12A and Interleukin-12B Genotypes to Colorectal Cancer in Taiwan.
    Anticancer Res. 2025;45:1501-1512.
    PubMed     Abstract available
    
    
    
87. NII T, Yoshimi T, Tanito K, Hijii S, et al
    Inflammation-triggering Engineered Macrophages (MacTriggers) Are Promising Cell-based Therapeutic Avenues for Chemoresistant Solid Tumors.
    Anticancer Res. 2025;45:1395-1405.
    PubMed     Abstract available
    
    
    
88. SUGIMOTO K, Irie T, Momose H, Kochi S, et al
    Circulating Tumor DNA Methylation Is a Biomarker of Poor Recurrence-free Survival in Locally-Advanced Rectal Cancer.
    Anticancer Res. 2025;45:1559-1573.
    PubMed     Abstract available
    
    
    March 2025
89. TERAISHI F, Yoshida Y, Shoji R, Kanaya N, et al
    Short-term Safety of Robot-assisted Rectal Surgery in Patients Aged >/=75 Years: A Single-center Retrospective Study.
    Anticancer Res. 2025;45:1291-1299.
    PubMed     Abstract available
    
    
    
90. WEISS TS, Buechler C
    Proprotein Convertase Subtilisin/Kexin Type 9 Induction in Hypercholesterinemic Patients With Primary and Metastatic Liver Tumors.
    Anticancer Res. 2025;45:1171-1180.
    PubMed     Abstract available
    
    
    
91. SHOJI R, Teraishi F, Kondo Y, Yoshida Y, et al
    Tailoring Neoadjuvant Therapy for Rectal Cancer: A Single-center Study of Local Recurrence Patterns.
    Anticancer Res. 2025;45:1261-1271.
    PubMed     Abstract available
    
    
    
92. GOTO K, Ryu S, Imaizumi Y, Iwauchi S, et al
    Urethral Visualization Using Near-infrared Light Observation During Transanal/Perineal Total Mesorectal Excision.
    Anticancer Res. 2025;45:1241-1249.
    PubMed     Abstract available
    
    
    
93. SUGIYAMA M, Kasagi Y, Yokomizo R, Terashi M, et al
    Oncologic Relevance and Anal Preservation Potential of Transanal Total Mesorectal Excision for Rectal Cancer Invading Adjacent Organs.
    Anticancer Res. 2025;45:1233-1239.
    PubMed     Abstract available
    
    
    February 2025
94. DREVS J, Malhotra MS, Sahinbas H, Iliopoulos A, et al
    Adjusting Treatment Strategies Using Circulating Tumor Cells: Preliminary Results on Metastatic Colorectal Cancer.
    Anticancer Res. 2025;45:491-502.
    PubMed     Abstract available
    
    
    
95. YANG IJ, Kim DH, Lee KH, Kim JY, et al
    Safety and Survival Benefit of Adjuvant Chemotherapy for Elderly Patients With Stage II/III Colon Cancer.
    Anticancer Res. 2025;45:797-809.
    PubMed     Abstract available
    
    
    
96. TAKISHIMA T, Kobayashi Y, Matsukida S, Kai W, et al
    Negative Impact of Low Serum Cholinesterase on Short- and Long-term Outcomes in Elderly Patients Undergoing Scheduled Surgery for Colorectal Cancer.
    Anticancer Res. 2025;45:743-750.
    PubMed     Abstract available
    
    
    January 2025
97. KAWAMURA H, Imaizumi T, Miyakawa T, Nakao E, et al
    Development of a Prognostic Model for Stage IV Colorectal Cancer Using Metastatic Patterns.
    Anticancer Res. 2025;45:341-350.
    PubMed     Abstract available
    
    
    
98. ZHANG Y, Li X, Li S, Yang Z, et al
    Alternating Oxaliplatin and Irinotecan Chemotherapy Combined With Capecitabine and Bevacizumab for Microsatellite-stable Stage IV Metastatic Colon Cancer With a BRAF V600E Mutation: Two Case Reports Indicating Survival Improvement over Standard Therap
    Anticancer Res. 2025;45:399-404.
    PubMed     Abstract available
    
    
    
99. KASUGA SO, Nozawa H, Ishihara S
    Changes in Mesorectal CT Values and Therapeutic Effect of Preoperative Chemoradiotherapy in Rectal Cancer.
    Anticancer Res. 2025;45:359-367.
    PubMed     Abstract available
    
    
    
100. ESKELINEN M, Selander T, Guimaraes DP, Kaarniranta K, et al
     Artificial Intelligence Models Could Enhance the Diagnostic Accuracy (DA) of Fecal Immunochemical Test (FIT) in the Detection of Colorectal Adenoma in a Screening Setting.
     Anticancer Res. 2025;45:267-275.
     PubMed     Abstract available
     
     
     
101. TSAI YY, Ke TW, Huang CH, Chen TW, et al
     Prognostic Relevance of Immunosuppressive CD155/TIGIT Signaling in Locally Advanced Rectal Cancer Patients With Neoadjuvant Chemoradiotherapy.
     Anticancer Res. 2025;45:323-333.
     PubMed     Abstract available
     
     
     December 2024
102. KIM HB, Choi WY, Kim SH, Lee HJ, et al
     GNAO1: A Novel Tumor Suppressor Gene in Colorectal Cancer Pathogenesis.
     Anticancer Res. 2024;44:5425-5433.
     PubMed     Abstract available
     
     
     
103. SHIBUTANI M, Kashiwagi S, Tanda H, Seki Y, et al
     Prognostic Significance of Innovative Inflammation-nutrition Biomarker Score in Patients With Colorectal Cancer.
     Anticancer Res. 2024;44:5559-5567.
     PubMed     Abstract available
     
     
     
104. SHIN H, Kim Y, Lee Y, Kim J, et al
     Chlorhexidine Dihydrochloride Shows Anti-tumor Effects in Desmoid Tumors and Colorectal Cancer.
     Anticancer Res. 2024;44:5435-5443.
     PubMed     Abstract available
     
     
     
105. LEE Y, Kim Y, Shin H, Ryu YC, et al
     Anti-tumor Effects of Idarubicin Hydrochloride in Desmoid Tumors.
     Anticancer Res. 2024;44:5313-5322.
     PubMed     Abstract available
     
     
     November 2024
106. ZADOROZNYJ A, Karam E, Michot N, Thiery J, et al
     Clinical and Oncological Impact of a Protective Ileostomy in Rectal Cancer Patients Undergoing Adjuvant Chemotherapy.
     Anticancer Res. 2024;44:4995-5005.
     PubMed     Abstract available
     
     
     
107. NGUYEN MLT, Pham C, Nguyen TS, Nham PLT, et al
     Single-agent Adavosertib Shows Anticancer Effects Against Colorectal Cancer Cells.
     Anticancer Res. 2024;44:4941-4949.
     PubMed     Abstract available
     
     
     
108. YASUI C, Kono Y, Ishiguro R, Yagyu T, et al
     New Treatment Modalities for Colorectal Cancer Through Simultaneous Suppression of FSP1 and GPX4.
     Anticancer Res. 2024;44:4905-4914.
     PubMed     Abstract available
     
     
     
109. SUNG YN, Kim Y, Datuin AT, Jang I, et al
     Routine Elastic Staining Helps Detection of Vascular Invasion in Colorectal Cancer: A Comprehensive Analysis of T3 or Higher Tumors Without Lymph Node Metastasis.
     Anticancer Res. 2024;44:5059-5065.
     PubMed     Abstract available
     
     
     October 2024
110. UNRUG-BIELAWSKA K, Earnshaw D, Cybulska-Lubak M, Kaniuga E, et al
     Therapeutic Responses to Two New SN-38 Derivatives in Colorectal Cancer Patient-Derived Xenografts and Respective 3D In Vitro Cultures.
     Anticancer Res. 2024;44:4219-4224.
     PubMed     Abstract available
     
     
     
111. RUBIO CA, Vieth M, Lang-Schwarz C
     Nondysplastic Colon Crypts Intercalated in Tubular Adenomas Support Field Cancerization.
     Anticancer Res. 2024;44:4371-4377.
     PubMed     Abstract available
     
     
     
112. HOSIK J, Hosikova B, Kolarova H, Bajgar R, et al
     5,10,15,20-Tetrakis(4-sulfonatophenyl)porphyrin Zinc and Chloro-aluminum Phthalocyanine Disulfonate in Photodynamic Therapy of Colorectal Adenocarcinoma In Vitro.
     Anticancer Res. 2024;44:4339-4346.
     PubMed     Abstract available
     
     
     
113. VIRGILIO E, Salvemini C, Treglia MG, Thai E, et al
     Hotspots of Anal Cancer Screening in a High-risk Population: A Clinical Study on Free Provision, Best Method, Self-sampling, and Independent Risk Factors.
     Anticancer Res. 2024;44:4465-4481.
     PubMed     Abstract available
     
     
     September 2024
114. HOSOKAWA A, Tamura H, Ichihara A, Imamura N, et al
     Pathological Complete Response to Liver Metastasis With Pembrolizumab in a Previously Treated Patient With Microsatellite Instability-high Colorectal Cancer.
     Anticancer Res. 2024;44:4119-4125.
     PubMed     Abstract available
     
     
     
115. SHIRAISHI T, Yamaguchi A, Shibasaki Y, Osone K, et al
     Risk Factors of Poor Outcomes After Colorectal Cancer Surgery for Patients With Severe Comorbidities.
     Anticancer Res. 2024;44:4073-4083.
     PubMed     Abstract available
     
     
     
116. COZZANI F, Ricchiuto M, Virgilio E, Viani L, et al
     The Controlling Nutritional Status (CONUT) Score Predicts Post-operatory Risks and Prognosis in Patients With Surgically Treated Colon Cancer: A Retrospective Study.
     Anticancer Res. 2024;44:3955-3964.
     PubMed     Abstract available
     
     
     
117. JINNO T, Yamaguchi J, Ogura A, Kokuryo T, et al
     Loss of Trefoil Factor 1 Accelerates the Immune Response to Colorectal Cancer.
     Anticancer Res. 2024;44:3757-3769.
     PubMed     Abstract available
     
     
     
118. FUKUSHIMA G, Sato E, Udo R, Tago T, et al
     Stromal CD4 (+) T Cell Subsets Mediate Antitumor Cytotoxic Immune Responses in Human Colorectal Carcinoma.
     Anticancer Res. 2024;44:3899-3906.
     PubMed     Abstract available
     
     
     
119. KAYANO H, Mamuro N, Kamei Y, Ogimi T, et al
     Risk Factors Associated With Perioperative Skeletal Muscle Loss in Patients With Colorectal Cancer.
     Anticancer Res. 2024;44:4019-4029.
     PubMed     Abstract available
     
     
     
120. TAKEDA K, Kikuchi Y, Sawada YU, Kumamoto T, et al
     Simultaneously Detected Liver and Lung Metastases from Colorectal Carcinoma: A Potential Treatment Strategy.
     Anticancer Res. 2024;44:3945-3954.
     PubMed     Abstract available
     
     
     August 2024
121. KAMADA T, Furukawa K, Takahashi J, Aida T, et al
     Preoperative Vertebral Fracture: A Prognostic Factor in Stage I-III Colorectal Cancer.
     Anticancer Res. 2024;44:3533-3541.
     PubMed     Abstract available
     
     
     
122. YOKOTA Y, Nozawa H, Sonoda H, Yokoyama Y, et al
     Indoleamine 2,3-Dioxygenase Inhibitor Suppresses Colon Cancer Cell Migration, Invasion, and Epithelial-Mesenchymal Transition.
     Anticancer Res. 2024;44:3337-3342.
     PubMed     Abstract available
     
     
     
123. TSUJIO G, Fukuoka T, Sugimoto A, Yonemitsu K, et al
     The Efficacy of Chemical Bowel Preparation Against Incisional Surgical Site Infection in Colorectal Cancer Surgery: A Propensity Score Matching Study.
     Anticancer Res. 2024;44:3473-3480.
     PubMed     Abstract available
     
     
     
124. FUKUDA J, Sudo T, Kikuchi M, Kawahara A, et al
     Identification of DNA Repair-related Genes as Biomarkers Reflecting MSI, TMB, and TIL in Colorectal Cancer.
     Anticancer Res. 2024;44:3567-3575.
     PubMed     Abstract available
     
     
     
125. TAKAHASHI H, Kojima D, Wada H, Hanaoka K, et al
     A Bridge to Curative Surgery for Obstructive Colorectal Cancer: Self-expandable Metallic Stent Versus Decompression Tube.
     Anticancer Res. 2024;44:3427-3441.
     PubMed     Abstract available
     
     
     
126. MUKOHYAMA J, Koizumi M, Yamashita K, Yoshimi A, et al
     Knockdown of CDX2 Induces microRNA-221 Up-regulation in Human Colon Cancer Cells.
     Anticancer Res. 2024;44:3553-3556.
     PubMed     Abstract available
     
     
     July 2024
127. KOMORI K, Yoshida M, Tsukushi S, Kinoshita T, et al
     Combined Pubic Arch and Ischial Bone Resection for Metachronous and Frequent Local Recurrences of Rectal Cancer.
     Anticancer Res. 2024;44:3205-3211.
     PubMed     Abstract available
     
     
     
128. LEE SH, Kim SA, Park SJ, Lee MY, et al
     NUAK2 Inhibitors, KHKI-01128 and KHKI-01215, Exhibit Potent Anticancer Activity Against SW480 Colorectal Cancer Cells.
     Anticancer Res. 2024;44:2909-2919.
     PubMed     Abstract available
     
     
     
129. SHIOI I, Ogawa H, Naito R, Endo M, et al
     Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer.
     Anticancer Res. 2024;44:3013-3023.
     PubMed     Abstract available
     
     
     
130. TSUMURAYA H, Mimura K, Nakajima S, Hanayama H, et al
     Tumor Infiltrating Effector Regulatory T Cells Express VEGF Receptor 2 in Patients With Colorectal Cancer.
     Anticancer Res. 2024;44:2933-2941.
     PubMed     Abstract available
     
     
     
131. KARLIKOVA M, Curillova M, Pecen L, Karnos V Jr, et al
     Evaluation of Serum Cytokeratines, Thymidine Kinase, and Growth Factors as Cancer Biomarkers in Colorectal Cancer.
     Anticancer Res. 2024;44:3105-3113.
     PubMed     Abstract available
     
     
     June 2024
132. MOON SU, Lee JH, Shah M, Yoon S, et al
     RRM2 Is a CTNNB1 Transport Regulator Promoting Colon Cancer Progression.
     Anticancer Res. 2024;44:2471-2485.
     PubMed     Abstract available
     
     
     
133. TOREN W, Sasor A, Ansari D, Andersson R, et al
     ARHGAP4 as a Prognostic Biomarker for Colon Liver Metastases After Surgical Resection.
     Anticancer Res. 2024;44:2597-2604.
     PubMed     Abstract available
     
     
     
134. MATSUDA A, Yamada T, Takahashi G, Matsumoto S, et al
     Significance of Adjuvant Chemotherapy for Obstructive Colorectal Cancer After Stent Placement: A Multicenter Retrospective Study.
     Anticancer Res. 2024;44:2737-2745.
     PubMed     Abstract available
     
     
     
135. LIM SC, Lee TB, Han SI
     Caffeic Acid Enhances Anticancer Drug-induced Apoptosis in Acid-adapted HCT116 Colon Cancer Cells.
     Anticancer Res. 2024;44:2587-2595.
     PubMed     Abstract available
     
     
     May 2024
136. WAGNER D, Karitnig R, Wienerroither V, Hau HM, et al
     Sarcopenic Obesity Promotes Recurrence in Patients Undergoing Resection for Colorectal Liver Metastases (CRLM).
     Anticancer Res. 2024;44:2177-2183.
     PubMed     Abstract available
     
     
     April 2024
137. WU CC, Su CC, Chen YH, Hsu CW, et al
     Comparative Effectiveness of Adjuvant Therapy on Survival in Patients With Metastatic Colorectal Cancer.
     Anticancer Res. 2024;44:1619-1628.
     PubMed     Abstract available
     
     
     
138. TANAKA H, Hayashi H, Tomita H, Tokumaru Y, et al
     Association of Preoperative and Postoperative Plasma Syndecan-1 and Colorectal Cancer Outcome.
     Anticancer Res. 2024;44:1611-1618.
     PubMed     Abstract available
     
     
     
139. SHIRAISHI T, Tominaga T, Ono R, Noda K, et al
     Short- and Long-term Outcomes After Colonic Stent Insertion as a Bridge to Surgery in Elderly Colorectal Cancer Patients.
     Anticancer Res. 2024;44:1637-1643.
     PubMed     Abstract available
     
     
     
140. SYRJANEN K, Eskelinen M, Meklin J, Hendolin P, et al
     Colorectal Cancer Screening by Fecal Immunochemical Tests (FIT): Considerations on Sampling and Markers (Hb and Hb/Hp Complex) of Fecal Occult Blood (FOB).
     Anticancer Res. 2024;44:1513-1523.
     PubMed     Abstract available
     
     
     
141. BEPPU T, Yamamura K, Masuda T, Miyamoto H, et al
     High-risk Patients With Colorectal Liver Metastases Assessed by the Beppu Score Can Have Excellent Survival Through Multidisciplinary Treatment Including Local Ablation.
     Anticancer Res. 2024;44:1533-1539.
     PubMed     Abstract available
     
     
     
142. SATOYOSHI T, Hirohashi Y, Okuya K, Miyo M, et al
     CD8-positive T Cell Infiltration With Human Leukocyte Antigen Class 1 Expression Predicts Patients With Stage IV Colorectal Cancer Survival.
     Anticancer Res. 2024;44:1603-1610.
     PubMed     Abstract available
     
     
     
143. AOYAMA T, Yukawa N, Saito A
     Clinical Impact of Nutrition and Inflammation Assessment Tools in Colorectal Cancer Treatment.
     Anticancer Res. 2024;44:1335-1351.
     PubMed     Abstract available
     
     
     March 2024
144. ZHENG W, Chen K, Lv Y, Lao W, et al
     Pyrvinium Pamoate Induces Cell Apoptosis and Autophagy in Colorectal Cancer.
     Anticancer Res. 2024;44:1193-1199.
     PubMed     Abstract available
     
     
     
145. EBATA Y, Nakanishi R, Tanaka Y, Kawazoe T, et al
     Neoadjuvant Chemotherapy in Patients With T4b or Obstructive Colon Cancer: A Single Center Retrospective Cohort Study.
     Anticancer Res. 2024;44:1281-1287.
     PubMed     Abstract available
     
     
     
146. HARA S, Sakai D, Ikemura K, Shintani T, et al
     Comparative Efficacy and Safety of Standard and Biweekly Trifluridine/Tipiracil Regimen in Patients With Colorectal Cancer.
     Anticancer Res. 2024;44:1219-1226.
     PubMed     Abstract available
     
     
     
147. SILVA EF, Fernandes BN, Marinello P, Deminice R, et al
     Pre and Post-high-intensity Interval Training Delays Colon Tumor Onset in a Syngeneic Mouse Model.
     Anticancer Res. 2024;44:1209-1217.
     PubMed     Abstract available
     
     
     
148. HEGEDUS D, Szemeredi N, Gabor M, Sas J, et al
     Cyclic Amines Coupled to Indole Derivatives With Improved Efflux Pump Inhibiting Activity in Bacteria and Cancer Cells.
     Anticancer Res. 2024;44:1149-1160.
     PubMed     Abstract available
     
     
     
149. ARDJMAND D, Kubota Y, Sato M, Han Q, et al
     Selective Synergy of Rapamycin Combined With Methioninase on Cancer Cells Compared to Normal Cells.
     Anticancer Res. 2024;44:929-933.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum